Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot Study

NCT04466969 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04466969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04466969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 31, 2020
Completion date
November 30, 2020
Enrollment
146 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia